NO170215C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater

Info

Publication number
NO170215C
NO170215C NO881199A NO881199A NO170215C NO 170215 C NO170215 C NO 170215C NO 881199 A NO881199 A NO 881199A NO 881199 A NO881199 A NO 881199A NO 170215 C NO170215 C NO 170215C
Authority
NO
Norway
Prior art keywords
lower alkyl
hydrogen
formula
preparation
therapeutic active
Prior art date
Application number
NO881199A
Other languages
English (en)
Norwegian (no)
Other versions
NO170215B (no
NO881199D0 (no
NO881199L (no
Inventor
Wilhelm Kloetzer
Marc Montavon
Renate Muessner
Nicolas Singewald
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO881199D0 publication Critical patent/NO881199D0/no
Publication of NO881199L publication Critical patent/NO881199L/no
Publication of NO170215B publication Critical patent/NO170215B/no
Publication of NO170215C publication Critical patent/NO170215C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88Nitrogen atoms, e.g. allantoin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Epoxy Resins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO881199A 1987-03-20 1988-03-18 Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater NO170215C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH107387 1987-03-20

Publications (4)

Publication Number Publication Date
NO881199D0 NO881199D0 (no) 1988-03-18
NO881199L NO881199L (no) 1988-09-21
NO170215B NO170215B (no) 1992-06-15
NO170215C true NO170215C (no) 1992-09-23

Family

ID=4201822

Family Applications (1)

Application Number Title Priority Date Filing Date
NO881199A NO170215C (no) 1987-03-20 1988-03-18 Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater

Country Status (23)

Country Link
US (1) US4908363A (da)
EP (1) EP0283857B1 (da)
JP (1) JPS63253070A (da)
KR (1) KR880011117A (da)
CN (1) CN1016169B (da)
AT (1) ATE73777T1 (da)
AU (1) AU613349B2 (da)
CS (1) CS276093B6 (da)
DE (1) DE3869163D1 (da)
DK (1) DK59888A (da)
ES (1) ES2032482T3 (da)
FI (1) FI880813A (da)
GR (1) GR3004729T3 (da)
HU (1) HU201312B (da)
IL (1) IL85725A (da)
MC (1) MC1919A1 (da)
MX (1) MX10721A (da)
NO (1) NO170215C (da)
NZ (1) NZ223862A (da)
PT (1) PT87025B (da)
SU (1) SU1657057A3 (da)
YU (1) YU46444B (da)
ZA (1) ZA881810B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5073566A (en) * 1989-11-30 1991-12-17 Eli Lilly And Company Angiotensin ii antagonist 1,3-imidazoles and use thereas
US5612360A (en) * 1992-06-03 1997-03-18 Eli Lilly And Company Angiotensin II antagonists
US5401851A (en) * 1992-06-03 1995-03-28 Eli Lilly And Company Angiotensin II antagonists
US5574057A (en) * 1993-02-03 1996-11-12 University Of Utah Research Foundation Naamidine A extracted from sea sponges and methods for its use as an anti-tumor agent
US5523310A (en) * 1994-12-05 1996-06-04 Hoffmann-La Roche Inc. 1,2,3-triazole derivatives
AU1383200A (en) 1998-11-23 2000-06-13 F. Hoffmann-La Roche Ag Synthesis of anti-inflammatory (1,2,3)triazoles
DE10132896A1 (de) * 2001-07-06 2003-01-16 Bayer Cropscience Ag Heterocyclische Amidderivate
WO2003010143A1 (en) 2001-07-26 2003-02-06 Samsung Electronics Co., Ltd. Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses
US6737433B1 (en) * 2002-12-16 2004-05-18 Laboratoire Theramex 1-N-phenylamino-1H-imidazole derivatives as aromatase inhibitors and pharmaceutical compositions containing them

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8120400A (da) * 1980-07-31 1982-06-01 Aleksandr Vasilevich Ivaschenko, Valentina Timofeevna Lazareva, Elena Karlovna Prudnikova, Vladimir Grigorievich Rumyantsev, Tamara Sergeevna Pljusnina Allen Te Dolgoprudny, Viktor Andreevich Nefedov, Lev Mikhailovich Blinov, Viktor Vasilievich Titov Allen Te Moskou, Vladimir Petrovich Sevostiyanov
DE3674054D1 (de) * 1985-04-26 1990-10-18 Hoffmann La Roche 1,3-disubstituierte imidazoliumsalze.
ZW6687A1 (en) * 1986-05-13 1987-12-02 Hoffmann La Roche 1,3-disubstituted imidazolium salts
MW7087A1 (en) * 1986-10-03 1988-05-11 Hoffmann La Roche 1,3-disubstituted imidazolium salts
KR890700582A (ko) * 1987-03-20 1989-04-25 사무엘 에스. 블라이트 살진균성 아미노트리아졸 및 아미노이미다졸

Also Published As

Publication number Publication date
MX10721A (es) 1993-09-01
HUT49581A (en) 1989-10-30
CN88101452A (zh) 1988-10-05
MC1919A1 (fr) 1989-04-06
AU1353288A (en) 1988-09-22
NO170215B (no) 1992-06-15
NO881199D0 (no) 1988-03-18
YU40388A (en) 1990-02-28
KR880011117A (ko) 1988-10-26
HU201312B (en) 1990-10-28
EP0283857A1 (de) 1988-09-28
NZ223862A (en) 1990-08-28
US4908363A (en) 1990-03-13
CS276093B6 (en) 1992-04-15
PT87025A (pt) 1988-04-01
AU613349B2 (en) 1991-08-01
SU1657057A3 (ru) 1991-06-15
EP0283857B1 (de) 1992-03-18
IL85725A0 (en) 1988-08-31
GR3004729T3 (da) 1993-04-28
DE3869163D1 (de) 1992-04-23
ES2032482T3 (es) 1993-02-16
JPS63253070A (ja) 1988-10-20
ATE73777T1 (de) 1992-04-15
NO881199L (no) 1988-09-21
CN1016169B (zh) 1992-04-08
FI880813A0 (fi) 1988-02-22
CS8800891A2 (en) 1990-09-12
DK59888A (da) 1988-09-21
ZA881810B (en) 1988-09-20
YU46444B (sh) 1993-10-20
FI880813A (fi) 1988-09-21
IL85725A (en) 1991-12-12
DK59888D0 (da) 1988-02-05
PT87025B (pt) 1992-06-30

Similar Documents

Publication Publication Date Title
SE7614539L (sv) Forfarande for framstellning av karbostyrilderivat med terapeutisk verkan
NO166126C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater.
GR3015616T3 (en) Aryl-heteroaryl-carbinol derivatives having an analgesic activity.
NO173867C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzamider
NO177007C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive tetrahydrobenzimidazolderivater
NO170215C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO164978C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heteroaryloxy-beta-carbolinderivater.
ES8800142A1 (es) Un procedimiento para preparar un derivado de semicarbazida
NO168418C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive bicykliske forbindelser
ES8307792A1 (es) Un metodo de produccion de compuesto de dihidropiridina.
NO168707C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterotetracykliske laktamderivater.
HK1000494A1 (en) Thiazolidinone or oxazolidinone derivatives to treat angina pectoris or compositions containing the same as active ingredient
CA2053705A1 (en) Piperazine derivatives
DK141187D0 (da) 1-(3-(2-dialkylaminoethoxy)-2-thienyl)-3-phenyl-1-propanoner og syreadditionssalte deraf, fremgangsmaade af saadanne forbindelser samt farmaceutiske praeparater indeholdende disse
IE802682L (en) Oxazoline derivatives
NO930844L (no) 2-(2-substituerte pyrrolidinyltio)karbapenem-derivater